You just read:

Valeant And One Of Its Subsidiaries Commence Cash Tender Offers For Up To $1,000,000,000 Outstanding Principal Amount

News provided by

Valeant Pharmaceuticals International, Inc.

Dec 04, 2017, 06:21 ET